La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Expleo Solutions Croissance future
Future contrôle des critères 0/6
Informations clés
n/a
Taux de croissance des bénéfices
30.4%
Taux de croissance du BPA
IT croissance des bénéfices | 10.6% |
Taux de croissance des recettes | n/a |
Rendement futur des capitaux propres | n/a |
Couverture par les analystes | Low |
Dernière mise à jour | 17 Jul 2024 |
Mises à jour récentes de la croissance future
Pas de mise à jour
Recent updates
When Should You Buy Expleo Solutions Limited (NSE:EXPLEOSOL)?
Jun 21Investors Could Be Concerned With Expleo Solutions' (NSE:EXPLEOSOL) Returns On Capital
Mar 15The Returns On Capital At Expleo Solutions (NSE:EXPLEOSOL) Don't Inspire Confidence
Sep 15Increases to Expleo Solutions Limited's (NSE:EXPLEOSOL) CEO Compensation Might Cool off for now
Aug 19Calculating The Fair Value Of Expleo Solutions Limited (NSE:EXPLEOSOL)
Jul 14Many Would Be Envious Of Expleo Solutions' (NSE:EXPLEOSOL) Excellent Returns On Capital
May 05A Look At The Fair Value Of Expleo Solutions Limited (NSE:EXPLEOSOL)
Mar 15Expleo Solutions Limited's (NSE:EXPLEOSOL) Stock Been Rising: Are Strong Financials Guiding The Market?
Feb 15Expleo Solutions (NSE:EXPLEOSOL) Knows How to Allocate Capital
Jan 24Introducing Expleo Solutions (NSE:EXPLEOSOL), A Stock That Climbed 76% In The Last Year
Jan 04A Look At The Intrinsic Value Of Expleo Solutions Limited (NSE:EXPLEOSOL)
Dec 14Is There More To The Story Than Expleo Solutions's (NSE:EXPLEOSOL) Earnings Growth?
Nov 26Prévisions de croissance des bénéfices et des revenus
Date | Recettes | Les revenus | Flux de trésorerie disponible | Cash from Op | Moy. Nombre d'analystes |
---|---|---|---|---|---|
3/31/2025 | 11,322 | N/A | N/A | N/A | 1 |
6/30/2024 | 9,919 | 942 | N/A | N/A | N/A |
3/31/2024 | 9,649 | 904 | 517 | 692 | N/A |
12/31/2023 | 9,405 | 1,038 | N/A | N/A | N/A |
9/30/2023 | 9,305 | 1,251 | 130 | 380 | N/A |
6/30/2023 | 9,152 | 1,311 | N/A | N/A | N/A |
3/31/2023 | 9,033 | 1,339 | -211 | 231 | N/A |
12/31/2022 | 5,072 | 823 | N/A | N/A | N/A |
9/30/2022 | 4,779 | 648 | 73 | 420 | N/A |
6/30/2022 | 4,439 | 583 | N/A | N/A | N/A |
3/31/2022 | 7,425 | 677 | -12 | 242 | N/A |
12/31/2021 | 3,703 | 463 | N/A | N/A | N/A |
9/30/2021 | 3,366 | 475 | 529 | 588 | N/A |
6/30/2021 | 3,131 | 490 | N/A | N/A | N/A |
3/31/2021 | 3,009 | 504 | 620 | 664 | N/A |
12/31/2020 | 2,971 | 534 | N/A | N/A | N/A |
9/30/2020 | 2,931 | 512 | 332 | 373 | N/A |
6/30/2020 | 2,852 | 475 | N/A | N/A | N/A |
3/31/2020 | 2,702 | 399 | 144 | 167 | N/A |
12/31/2019 | 2,627 | 353 | N/A | N/A | N/A |
9/30/2019 | 2,614 | 298 | 274 | 295 | N/A |
6/30/2019 | 2,741 | 345 | N/A | N/A | N/A |
3/31/2019 | 2,865 | 362 | 382 | 406 | N/A |
12/31/2018 | 2,973 | 372 | N/A | N/A | N/A |
9/30/2018 | 2,949 | 377 | N/A | N/A | N/A |
6/30/2018 | 2,898 | 313 | N/A | N/A | N/A |
3/31/2018 | 2,764 | 320 | N/A | 250 | N/A |
12/31/2017 | 2,583 | 256 | N/A | N/A | N/A |
9/30/2017 | 2,488 | 243 | N/A | N/A | N/A |
6/30/2017 | 2,475 | 230 | N/A | N/A | N/A |
3/31/2017 | 2,599 | 238 | N/A | 423 | N/A |
12/31/2016 | 2,747 | 293 | N/A | N/A | N/A |
9/30/2016 | 2,809 | 329 | N/A | N/A | N/A |
6/30/2016 | 2,790 | 372 | N/A | N/A | N/A |
3/31/2016 | 2,642 | 369 | N/A | 577 | N/A |
12/31/2015 | 2,445 | 279 | N/A | N/A | N/A |
9/30/2015 | 2,312 | 271 | N/A | N/A | N/A |
6/30/2015 | 2,212 | 240 | N/A | N/A | N/A |
3/31/2015 | 2,142 | 216 | N/A | 334 | N/A |
12/31/2014 | 2,116 | 222 | N/A | N/A | N/A |
9/30/2014 | 2,087 | 226 | N/A | N/A | N/A |
6/30/2014 | 2,027 | 261 | N/A | N/A | N/A |
3/31/2014 | 1,944 | 300 | N/A | 237 | N/A |
12/31/2013 | 1,819 | 300 | N/A | N/A | N/A |
9/30/2013 | 1,725 | 290 | N/A | N/A | N/A |